HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hélène Péré Selected Research
Hélène Péré Research Topics
Disease
25
COVID-19
05/2024 - 01/2020
12
Infections
10/2023 - 02/2014
6
Papillomavirus Infections
10/2023 - 01/2018
6
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 01/2019
3
Breakthrough Infections
01/2023 - 11/2022
3
Neoplasms (Cancer)
04/2021 - 09/2009
3
Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 01/2018
2
Neoplasm Metastasis (Metastasis)
01/2023 - 01/2023
2
Carcinoma (Carcinomatosis)
01/2021 - 09/2020
2
Papilloma (Papillomatosis)
01/2021 - 10/2020
2
Squamous Cell Carcinoma of Head and Neck
01/2020 - 11/2018
2
Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 01/2018
1
Chronic Renal Insufficiency
12/2023
1
Pneumonia (Pneumonitis)
01/2023
1
Emerging Communicable Diseases (Emerging Infectious Diseases)
12/2022
1
Critical Illness (Critically Ill)
05/2022
1
Fever (Fevers)
01/2022
1
COVID-19 rebound
01/2022
1
Communicable Diseases (Infectious Diseases)
01/2022
1
Pancreatic Neoplasms (Pancreatic Cancer)
04/2021
1
Cytokine Release Syndrome
01/2021
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1
Hematologic Neoplasms (Hematological Malignancy)
11/2020
1
Bacterial Pneumonia
11/2020
1
Autoimmune Diseases (Autoimmune Disease)
11/2020
1
Lymphopenia (Lymphocytopenia)
11/2020
1
Acquired Immunodeficiency Syndrome (AIDS)
05/2020
1
Oropharyngeal Neoplasms
01/2020
1
Disease Progression
01/2020
1
Inflammation (Inflammations)
01/2020
1
Carcinogenesis
11/2019
1
Anus Neoplasms (Anal Cancer)
01/2019
1
Herpes Genitalis (Genital Herpes)
05/2014
1
Syphilis
12/2013
Drug/Important Bio-Agent (IBA)
9
DNA (Deoxyribonucleic Acid)
IBA
10/2023 - 02/2014
8
Monoclonal Antibodies
IBA
05/2023 - 11/2020
7
Vaccines
IBA
10/2023 - 01/2019
7
RNA (Ribonucleic Acid)
IBA
01/2023 - 01/2018
5
Biomarkers (Surrogate Marker)
IBA
01/2022 - 11/2018
5
Antibodies
IBA
01/2022 - 12/2013
5
Immunoglobulin G (IgG)
IBA
01/2021 - 01/2020
3
Neutralizing Antibodies
IBA
10/2023 - 01/2021
3
N-(2-cyanoethylene)urea (BA 1)
IBA
01/2023 - 11/2022
3
N-methyl-valyl-amiclenomycin (BA 2)
IBA
01/2023 - 11/2022
3
Immunoglobulin M (IgM)
IBA
01/2021 - 11/2020
2
Cytokines
IBA
05/2024 - 11/2021
2
tixagevimab
IBA
05/2023 - 12/2022
2
cilgavimab
IBA
05/2023 - 12/2022
2
Antiviral Agents (Antivirals)
IBA
05/2022 - 05/2014
2
COVID-19 Vaccines
IBA
01/2022 - 01/2021
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
05/2024
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
05/2024
1
nirmatrelvir
IBA
12/2023
1
Ritonavir (Norvir)
FDA Link
12/2023
1
nirmatrelvir and ritonavir drug combination
IBA
05/2023
1
imdevimab
IBA
05/2023
1
sotrovimab
IBA
05/2023
1
casirivimab
IBA
05/2023
1
Peptide Hydrolases (Proteases)
FDA Link
05/2023
1
Interferons
IBA
01/2023
1
Oxygen (Dioxygen)
IBA
01/2023
1
Immunoglobulin A (IgA)
IBA
12/2022
1
BNT162 Vaccine
IBA
12/2022
1
cilgavimab and tixagevimab drug combination
IBA
12/2022
1
casirivimab and imdevimab drug combination
IBA
01/2022
1
Rituximab (Mabthera)
FDA Link
01/2022
1
Ribonuclease P (RNase P)
IBA
01/2022
1
Nucleocapsid Proteins
IBA
05/2021
1
Antigens
IBA
05/2021
1
Bevacizumab (Avastin)
FDA Link
04/2021
1
Platinum
IBA
04/2021
1
Poly(ADP-ribose) Polymerase Inhibitors
IBA
04/2021
1
olaparib
IBA
04/2021
1
Carboplatin (JM8)
FDA Link
Generic
04/2021
1
Paclitaxel (Taxol)
FDA Link
Generic
04/2021
1
Cholinergic Agents (Cholinergics)
IBA
01/2021
1
Acetylcholine (Acetylcholine Chloride)
FDA Link
01/2021
1
Eosine Yellowish-(YS) (Eosin)
IBA
01/2021
1
Hematoxylin (Haematoxylon)
IBA
01/2021
1
Nicotine
FDA Link
01/2021
1
Nucleic Acids
IBA
11/2020
1
Messenger RNA (mRNA)
IBA
10/2020
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2020
1
Interleukin-6 (Interleukin 6)
IBA
01/2020
1
Interferon Type I
IBA
01/2020
1
Oncogene Proteins (Oncogene Protein)
IBA
11/2019
1
Viral DNA
IBA
11/2019
1
Paraffin
IBA
01/2019
1
Nucleotides
IBA
01/2019
1
Formaldehyde (Formol)
FDA Link
01/2019
1
DNA-Directed DNA Polymerase (Polymerases, DNA)
IBA
01/2018
Therapy/Procedure
7
Therapeutics
05/2022 - 09/2009
1
Secondary Prevention
12/2022
1
Aftercare (After-Treatment)
12/2022
1
Chemoradiotherapy
04/2021
1
Artificial Respiration (Mechanical Ventilation)
11/2020